TCF7L2 and Impaired glucose tolerance: Another explanation could be that, because subjects carrying TCF7L2 diabetic risk-alleles are more likely to have progression from impaired glucose tolerance to T2DM [8], the duration of exposure of T2DM could be longer in risk-allele carriers compared to diabetic patients with the wild-type genotype, promoting the progress of atherogenesis.